Stephanie Hagen

Stephanie Hagen has over 19 years of experience in various roles within the pharmaceutical and scientific instrument industries. Stephanie began their career at PerkinElmer in 2001, where they worked as a Sales Specialist until 2004. In 2007, they joined Shimadzu Scientific Instruments as a Sales Engineer.

Hagen then transitioned into business development roles, starting with MDS Pharma Services in 2008, where they worked as a Director of Business Development until 2010. Stephanie was retained through an acquisition and represented discovery pharmacology and full toxicology services.

From 2010 to 2012, Hagen worked as a Director of Business Development at Ricerca Biosciences LLC, which was a former division of MDS Pharma Services. Stephanie was again retained through an acquisition and was responsible for maintaining and growing the client base in the US Southwest.

In 2012, Hagen moved to Eurofins Panlabs, another former division of Ricerca/MDS Pharma Services, where they continued to support and grow west coast accounts for discovery pharmacology and early safety screening services. Stephanie was once again retained through an acquisition and remained in this role until 2013.

Hagen's most recent position was as a Senior Director of Business Development at Celerion, Inc., which they started in June 2013. The details of their role at this company are not specified.

Stephanie Hagen earned a Master of Science (MS) degree in Biology from Georgia State University. Additionally, they attended NHI, though the specific degree and field of study are not specified.